You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Relationship Between the HLA-B*1502 Allele and Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis
|
|---|---|
| Published in |
JAMA Dermatology, September 2013
|
| DOI | 10.1001/jamadermatol.2013.4114 |
| Pubmed ID | |
| Authors |
Wimonchat Tangamornsuksan, Nathorn Chaiyakunapruk, Ratchadaporn Somkrua, Manupat Lohitnavy, Wichittra Tassaneeyakul |
| Abstract |
The US Food and Drug Administration recommends screening for the HLA-B*1502 allele before initiation of carbamazepine therapy in patients of Asian ancestry, but there remains unclear evidence of a relationship between HLA-B*1502 and Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) among carbamazepine users, especially in some racial/ethnic populations. |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 20% |
| Canada | 1 | 10% |
| Montenegro | 1 | 10% |
| Spain | 1 | 10% |
| Unknown | 5 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 50% |
| Scientists | 4 | 40% |
| Practitioners (doctors, other healthcare professionals) | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 181 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Unknown | 180 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 25 | 14% |
| Student > Ph. D. Student | 22 | 12% |
| Student > Bachelor | 20 | 11% |
| Researcher | 19 | 10% |
| Other | 12 | 7% |
| Other | 32 | 18% |
| Unknown | 51 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 60 | 33% |
| Pharmacology, Toxicology and Pharmaceutical Science | 27 | 15% |
| Biochemistry, Genetics and Molecular Biology | 10 | 6% |
| Agricultural and Biological Sciences | 7 | 4% |
| Nursing and Health Professions | 5 | 3% |
| Other | 17 | 9% |
| Unknown | 55 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2023.
All research outputs
#7,312,589
of 25,402,889 outputs
Outputs from JAMA Dermatology
#3,111
of 6,504 outputs
Outputs of similar age
#59,840
of 212,518 outputs
Outputs of similar age from JAMA Dermatology
#25
of 105 outputs
Altmetric has tracked 25,402,889 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 6,504 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.6. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,518 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 105 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.